Evidence of Oral Translocation of Anionic G6.5 Dendrimers in Mice
- 25 January 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 10 (3) , 988-998
Abstract
Development of carrier systems to improve oral bioavailability and target drugs to specific sites continues to be an unmet need. The goal of this study was to evaluate the potential of anionic generation (G) 6.5 poly(amido amine) (PAMAM) dendrimers in oral drug delivery by assessing their in vivo oral translocation. G6.5-COOH dendrimers were characterized for their physiochemical characteristics and acute oral toxicity was assessed in CD-1 mice. The dendrimers were labeled with 125I and their stability evaluated. Oral bioavailability was assessed in the same mouse model. Investigation of the radioactivity profile in plasma revealed presence of both large and small molecular weight compounds. Detailed area under the curve analysis suggests an effective 9.4% bioavailability of radiolabeled marker associated with G6.5-COOH. Results reported here suggest the potential of dendrimers in permeating gastrointestinal barriers in vivo.Keywords
This publication has 51 references indexed in Scilit:
- Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug deliveryAdvanced Drug Delivery Reviews, 2012
- Targeted Dendrimer Chemotherapy in an Animal Model for Head and Neck Squamous Cell CarcinomaJournal of Oral and Maxillofacial Surgery, 2011
- Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticlesNanotoxicology, 2011
- Chitosan–Sodium Lauryl Sulfate Nanoparticles as a Carrier System for the In Vivo Delivery of Oral InsulinAAPS PharmSciTech, 2011
- Folate‐targeted nanoparticles show efficacy in the treatment of inflammatory arthritisArthritis & Rheumatism, 2011
- Injectable PAMAM Dendrimer–PEG Hydrogels for the Treatment of Genital Infections: Formulation and in Vitro and in Vivo EvaluationMolecular Pharmaceutics, 2011
- Transfer of PAMAM dendrimers across human placenta: Prospects of its use as drug carrier during pregnancyJournal of Controlled Release, 2011
- G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicityJournal of Controlled Release, 2011
- PAMAM-Camptothecin Conjugate Inhibits Proliferation and Induces Nuclear Fragmentation in Colorectal Carcinoma CellsPharmaceutical Research, 2010
- Polymer conjugates as anticancer nanomedicinesNature Reviews Cancer, 2006